TITLE

Role of determination of hyperglycosylated HCG in prenatal diagnosis of Down syndrome

AUTHOR(S)
Shirali, S.; Abyaz, S.; Mirlohi, M.
PUB. DATE
June 2014
SOURCE
Iranian Journal of Reproductive Medicine;Jun2014 Supplement, Vol. 12, p80
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Introduction: Down syndrome is a genetic condition that occurs in approximately one in 691 live births. It is considered the most common chromosomal syndrome; therefore, prenatal diagnosis of this anomaly is important. Down syndrome screening is most often performed using the triple test: a-fetoprotein (AFP), 4 unconjugated estriol (uE3), and human chorionic gonadotropin (HCG). Moving screening into the first trimester has the advantage of earlier diagnosis. Hyperglycosylated human chorionic gonadotropin (HhCG) is a glycoprotein hormone secreted during embryonic implantation and trophoblast invasion of the uterine wall. Because the cytotrophoblasts are primitive and invasive in nature, HhCG is also called invasive trophoblast antigen (ITA). Invasive trophoblast antigen is a promising marker that can be measured in urine or serum. Materials and Methods: For study of relationship between ITA and Down syndrome we searched in PubMed, Sciencedirect, and Google scholar with key word for ITA, HhCG, and Down syndrome Results: Using IRMAs and ELISAs, investigators showed that A)HhCG rapidly increases in early pregnancy, attaining substantially higher concentrations and decreasing earlier than hCG; B) HhCG is increased in Down syndrome- affected pregnancies in both the first and second trimesters; and C) the HhCG:hCG ratio appears to be higher in those with invasive- noninvasive trophoblastic disease. Conclusion: Data indicate preliminary confirmation of the potential usefulness of urinary ITA measurements in detecting Down syndrome in a setting that simulates routine usage Serum ITA appears to be a useful first trimester Down syndrome marker that could replace of other markers mentioned.
ACCESSION #
96841680

 

Related Articles

  • Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin . Spencer, Kevin; Carpenter, Paul // BMJ: British Medical Journal (International Edition);9/25/93, Vol. 307 Issue 6907, p764 

    Investigates the value and impact of a screening program for Down's syndrome with free beta chorionic gonadotropin. Connection between low maternal serum concentration of alpha fetoprotein and babies affected by fetal trisomy; Benefits of the screening program using free beta chorionic...

  • A link between high serum levels of human chorionic gonadotrophin and chorionic expression of its mature functional receptor (LHCGR) in Down's syndrome pregnancies. Banerjee, Subhasis; Smallwood, Alan; Chambers, Anne E.; Papageorghiou, Aris; Loosfelt, Hugues; Spencer, Kevin; Campbell, Stuart; Nicolaides, Kypros // Reproductive Biology & Endocrinology;2005, Vol. 3, p25 

    Human chorionic gonadotrophin (hCG) is released from placental trophoblasts and is involved in establishing pregnancy by maintaining progesterone secretion from the corpus luteum. Serum hCG is detected in the maternal circulation within the first 2-3 wks of gestation and peaks at the end of the...

  • What factors regulate HCG production in Down's syndrome pregnancies? Goshen, Ran // MHR: Basic Science of Reproductive Medicine;Oct99, Vol. 5 Issue 10, p893 

    Discusses the factors that regulate human chorionic gonadotrophin (HCG) production in Down's syndrome (DS) pregnancies. Multisyetmic nature of DS; Biomolecular characteristics of HCG production in DS pregnancies; Importance of understanding the factors that mediate increased HCG concentrations...

  • Specific Measurement of O-Linked Core 2 Sugar-Containing Isoforms of Hyperglycosylated Human Chorionic Gonadotropin by Antibody B152. Birken, Steven // Tumor Biology (Springer Science & Business Media B.V.);May/Jun2005, Vol. 26 Issue 3, p131 

    There have been a significant number of reports on the clinical utility of measurement of ‘hyperglycosylated’ isoforms of the pregnancy hormone, human chorionic gonadotropin (hCG). Although there are a variety of hCG isoforms which can be termed ‘hyperglycosylated’, the...

  • What factors regulate HCG production in Down's syndrome pregnancies? Knöfler, Martin // MHR: Basic Science of Reproductive Medicine;Oct99, Vol. 5 Issue 10, p895 

    Discusses the factors that regulate human chorionic gonadotrophin (HCG) production in Down's syndrome pregnancies. Importance of HCG for successful maintenance of human pregnancy; Extraordinary expression pattern of HCG; Up-regulation of HCG by a putative transcription factor of the extra...

  • Maternal serum median levels of alpha-foetoprotein, human chorionic gonadotropin & unconjugated estriol in second trimester in pregnant women from north-west India. Kaur, Gurjit; Srivastav, Jyoti; Sharma, Suresh; Huria, Anju; Goel, Poonam; Singh Chavan, Bir // Indian Journal of Medical Research;Jul2013, Vol. 138 Issue 1, p83 

    Background & objectives: Triple test as prenatal screening procedure does not form a part of routine health care of pregnant women in India. Hence, median values of triple test biomarkers are lacking for Indian population. This study was undertaken to establish population-specific medians for...

  • DOWN SYNDROME CAN BE DETECTED IN FIRST TRIMESTER OF PREGNANCY. White, Kristin // Journal of Women's Health;Jun98, Vol. 7 Issue 5, p497 

    The article discusses the diagnosis of Down's Syndrome during pregnancy. It suggests that, by using two blood tests instead of the standard one may detect Down syndrome as early as the first trimester of pregnancy. Blood levels of pregnancy associated protein A and human chorionic gonadotropin...

  • triple-marker test.  // Taber's Cyclopedic Medical Dictionary;2005, p2240 

    A definition of "triple-marker test" is presented. It refers to the testing for Down syndrome in which the maternal serum levels of alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol are assessed. The test is also used as an alternative to amniocentesis.

  • Stability of inhibin A and unconjugated oestriol in the second trimester of pregnancy. Brown, Louise F.; Shearing, Catherine H.; Tydeman, Graham // Annals of Clinical Biochemistry;Jan2011, Vol. 48 Issue 1, p72 

    Background: The introduction of a second trimester quadruple test for fetal Down's syndrome adds the measurement of serum inhibin A (InhA) and unconjugated oestriol (UE3) to the existing repertoire of alphafetoprotein and intact human chorionic gonadotrophin. The aim of this study was to assess...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics